TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 19 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $89,938 | +36.6% | 47,586 | +7.7% | 0.00% | – |
| Q4 2022 | $65,846 | -20.7% | 44,192 | -11.3% | 0.00% | – |
| Q3 2022 | $83,000 | -9.8% | 49,818 | +8.8% | 0.00% | – |
| Q2 2022 | $92,000 | -84.5% | 45,800 | -79.6% | 0.00% | – |
| Q1 2022 | $592,000 | -8.1% | 224,943 | -3.2% | 0.00% | – |
| Q4 2021 | $644,000 | +30.9% | 232,475 | +82.5% | 0.00% | – |
| Q3 2021 | $492,000 | +147.2% | 127,366 | +315.4% | 0.00% | – |
| Q2 2021 | $199,000 | -37.0% | 30,662 | -20.0% | 0.00% | – |
| Q1 2021 | $316,000 | +119.4% | 38,332 | +211.3% | 0.00% | – |
| Q4 2020 | $144,000 | +193.9% | 12,315 | -50.3% | 0.00% | – |
| Q2 2020 | $49,000 | +28.9% | 24,769 | +54.3% | 0.00% | – |
| Q4 2019 | $38,000 | – | 16,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $9,746,000 | 1.82% |
| Altium Capital Management LP | 785,341 | $3,039,000 | 0.80% |
| Ikarian Capital, LLC | 2,691,110 | $10,415,000 | 0.73% |
| Telemetry Investments, L.L.C. | 130,500 | $505,000 | 0.68% |
| Psagot Value Holdings Ltd. | 143,591 | $556,000 | 0.10% |
| Psagot Value Holdings Ltd. / (Israel) | 143,591 | $556,000 | 0.10% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $110,000 | 0.06% |
| X-Square Capital, LLC | 17,973 | $70,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 85,993 | $333,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $1,038,000 | 0.03% |